Ken Griffin Medical Devices

Citadel Advisors LLC

$550 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
EW Edwards Lifesciences Corp	$47.6B	$996 Million 0.18% of portfolio	12,731,291	Q2 2025 Reduced 4.86%
MDT Medtronic PLC	$122B	$854 Million 0.16% of portfolio	9,796,855	Q2 2025 Added 13.11%
BSX Boston Scientific Corp	$147B	$580 Million 0.11% of portfolio	5,404,305	Q2 2025 Reduced 0.54%
ALGN Align Technology Inc	$11B	$317 Million 0.06% of portfolio	1,673,552	Q2 2025 Added 3.91%
PODD Insulet Corp	$21.5B	$242 Million 0.04% of portfolio	771,548	Q2 2025 Added 435.98%
DXCM Dexcom Inc	$31B	$119 Million 0.02% of portfolio	1,368,728	Q2 2025 Reduced 35.66%
BRKR Bruker Corp	$4.79B	$112 Million 0.02% of portfolio	2,712,456	Q2 2025 Added 114.82%
PEN Penumbra Inc	$9.42B	$56.2 Million 0.01% of portfolio	218,992	Q2 2025 Reduced 72.08%
ITGR Integer Holdings Corp	$3.56B	$53.4 Million 0.01% of portfolio	434,440	Q2 2025 Added 1,606.36%
GKOS Glaukos Corp	$4.25B	$33.1 Million 0.01% of portfolio	320,512	Q2 2025 Reduced 23.78%
STE Steris PLC	$24.4B	$25.1 Million 0.0% of portfolio	104,361	Q2 2025 Added 5,219.11%
SMLR Semler Scientific, Inc.	$235M	$23.9 Million 0.0% of portfolio	617,297	Q2 2025 Added 4,048.78%
TMDX Trans Medics Group, Inc.	$4.17B	$21 Million 0.0% of portfolio	156,441	Q2 2025 Reduced 74.34%
IRTC I Rhythm Technologies, Inc.	$4.87B	$15.4 Million 0.0% of portfolio	100,023	Q2 2025 Added 3,124.47%
RXST Rx Sight, Inc.	$203M	$13.4 Million 0.0% of portfolio	1,027,863	Q2 2025 Added 346.47%
UFPT Ufp Technologies Inc	$1.66B	$12.9 Million 0.0% of portfolio	52,857	Q2 2025 Added 36.18%
DCTH Delcath Systems, Inc.	$93.5M	$10.9 Million 0.0% of portfolio	803,208	Q2 2025 Added 539.74%
LIVN Liva Nova PLC	$2.71B	$8.31 Million 0.0% of portfolio	184,579	Q2 2025 Added 20.47%
SIBN Si Bone, Inc.	$521M	$7.52 Million 0.0% of portfolio	399,515	Q2 2025 Added 174.52%
TNDM Tandem Diabetes Care Inc	$713M	$6.58 Million 0.0% of portfolio	352,959	Q2 2025 Added 209.52%
BFLY Butterfly Network, Inc.	$241M	$5.41 Million 0.0% of portfolio	2,705,668	Q2 2025 Added 33.26%
VREX Varex Imaging Corp	$422M	$4.96 Million 0.0% of portfolio	571,996	Q2 2025 Added 56.46%
AORT Artivion, Inc.	$1.74B	$4.76 Million 0.0% of portfolio	153,145	Q2 2025 Added 1,308.1%
INMD In Mode Ltd.	$1.18B	$4.23 Million 0.0% of portfolio	292,613	Q2 2025 Added 30.97%
IART Integra Lifesciences Holdings Corp	$1.15B	$3.31 Million 0.0% of portfolio	270,062	Q2 2025 Added 24.13%
AVNS Avanos Medical, Inc.	$502M	$2.38 Million 0.0% of portfolio	194,722	Q2 2025 Added 47.3%
MXCT Maxcyte, Inc.	$129M	$2.24 Million 0.0% of portfolio	1,028,075	Q2 2025 Added 332.62%
CTKB Cytek Biosciences, Inc.	$543M	$2.1 Million 0.0% of portfolio	617,085	Q2 2025 Added 2.42%
ESTA Establishment Labs Holdings Inc.	$816M	$2.09 Million 0.0% of portfolio	48,979	Q2 2025 Reduced 34.78%
SNN Smith & Nephew PLC	$15.8B	$2.02 Million 0.0% of portfolio	65,840	Q2 2025 Reduced 65.25%
ATEC Alphatec Holdings, Inc.	$1.65B	$1.87 Million 0.0% of portfolio	168,153	Q2 2025 Reduced 69.92%
SRDX Surmodics Inc	$531M	$1.85 Million 0.0% of portfolio	62,353	Q2 2025 Reduced 10.07%
CERS Cerus Corp	$228M	$1.45 Million 0.0% of portfolio	1,029,213	Q2 2025 Reduced 23.81%
PHG Koninklijke Philips Nv	$23.9B	$1.32 Million 0.0% of portfolio	55,091	Q2 2025 Added 522.43%
INGN Inogen Inc	$173M	$1.14 Million 0.0% of portfolio	161,711	Q2 2025 Reduced 45.4%
INSP Inspire Medical Systems, Inc.	$2.39B	$1.13 Million 0.0% of portfolio	8,675	Q2 2025 Reduced 85.61%
CNMD Conmed Corp	$1.65B	$1.05 Million 0.0% of portfolio	20,110	Q2 2025 New
VMD Viemed Healthcare, Inc.	$284M	$1 Million 0.0% of portfolio	144,986	Q2 2025 Added 483.05%
KIDS Orthopediatrics Corp	$449M	$952,000 0.0% of portfolio	44,356	Q2 2025 Added 217.37%
CLPT Clear Point Neuro, Inc.	$258M	$950,000 0.0% of portfolio	79,569	Q2 2025 Added 551.72%
BWAY Brainsway Ltd.	$201M	$800,000 0.0% of portfolio	60,896	Q2 2025 Reduced 40.48%
MYO Myomo, Inc.	$7.84M	$701,000 0.0% of portfolio	324,590	Q2 2025 Added 22.98%
BIO Bio Rad Laboratories, Inc.	$6.77B	$631,000 0.0% of portfolio	2,618	Q2 2025 Reduced 79.56%
SENS Senseonics Holdings, Inc.	$219M	$612,000 0.0% of portfolio	1,276,729	Q2 2025 Added 44.06%
ELMD Electromed, Inc.	$164M	$593,000 0.0% of portfolio	26,968	Q2 2025 Added 65.43%
PRCT Procept Bio Robotics Corp	$1.72B	$459,000 0.0% of portfolio	7,986	Q2 2025 Reduced 38.32%
TMCI Treace Medical Concepts, Inc.	$362M	$348,000 0.0% of portfolio	59,230	Q2 2025 Reduced 78.17%
SGHT Sight Sciences, Inc.	$203M	$339,000 0.0% of portfolio	82,163	Q2 2025 Reduced 62.82%
RCEL Avita Medical, Inc.	$138M	$310,000 0.0% of portfolio	58,761	Q2 2025 New
ANIK Anika Therapeutics, Inc.	$127M	$298,000 0.0% of portfolio	28,253	Q2 2025 Reduced 58.72%

Shares Options

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Ken Griffin's portfolio

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account